FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:919-932 March 6, 2003 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The annual incidence of colorectal cancer in the United States is approximately 148,300 (affecting 72,600 males and 75,700 females), with 56,600 deaths (in 27,800 males and 28,800 females).¹ The lifetime risk of colorectal cancer in the general population is about 5 to 6 percent.¹ Patients with a familial risk — those who have two or more first- or second-degree relatives (or both) with colorectal cancer — make up approximately 20 percent of all patients with colorectal cancer, whereas approximately 5 to 10 percent of the total annual burden of colorectal cancer is mendelian in nature — that is, it is . . . [Full Text of this Article]

Overall Clinical Approach

Diagnostic Clues

Familial Adenomatous Polyposis

Clinical and Molecular Features

Genetic Testing

Chemoprevention

Hereditary Nonpolyposis Colorectal Cancer

Clinical Features

Pathological Features

Accelerated Carcinogenesis

Features of Pedigrees

Incidence and Molecular Screening

Genes and Germ-Line Mutations

Assessing the Pathogenicity of Mutations

Sources of Underdiagnosis

Surveillance for Cancer

Efficacy of Surveillance

Somatic Mutations and the Progression to Cancer

Role of Epigenetics

Hamartomatous Polyposis Syndromes

Prospects for Prevention and Treatment

Source Information

From the Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebr. (H.T.L.); and the Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, Columbus (A.C.).

Address reprint requests to Dr. Lynch at the Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, or at htlynch@creighton.edu.

Related Letters:

Genetics of Colorectal Cancer
Chan W. M., Pang C. P., Lam D. S.C., Gripp K. W.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:2361-2362, Jun 5, 2003. Correspondence

This article has been cited by other articles:

• Lippman, S. M., Hawk, E. T. (2009). Cancer Prevention: From 1727 to Milestones of the Past 100 Years. Cancer Res. 69: 5269-5284 [Abstract] [Full Text]  
• Lippman, S. M. (2009). Cancer Prevention Research: Back to the Future. Cancer Prevention Research 2: 503-513 [Full Text]  
• Fre, S., Pallavi, S. K., Huyghe, M., Lae, M., Janssen, K.-P., Robine, S., Artavanis-Tsakonas, S., Louvard, D. (2009). Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. USA 106: 6309-6314 [Abstract] [Full Text]  
• Pouchet, C. J., Wong, N., Chong, G., Sheehan, M. J., Schneider, G., Rosen-Sheidley, B., Foulkes, W., Tischkowitz, M. (2009). A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. Ann Oncol 20: 681-688 [Abstract] [Full Text]  
• Iwaizumi, M, Shinmura, K, Mori, H, Yamada, H, Suzuki, M, Kitayama, Y, Igarashi, H, Nakamura, T, Suzuki, H, Watanabe, Y, Hishida, A, Ikuma, M, Sugimura, H (2009). Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer. Gut 58: 249-260 [Abstract] [Full Text]  
• Lynch, H. T., Gatalica, Z., Knezetic, J. (2009). Molecular Genetics and Hereditary Colorectal Cancer: Resolution of the Diagnostic Dilemma of Hereditary Nonpolyposis Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer Type X, and Multiple Polyposis Syndromes. Am Soc Clin Oncol Ed Book 2009: 221-226 [Abstract] [Full Text]  
• Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T., Westman, J. A., Panescu, J., Fix, D., Lockman, J., LaJeunesse, J., Comeras, I., de la Chapelle, A. (2008). Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer. JCO 26: 5783-5788 [Abstract] [Full Text]  
• Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brunner, N., Chan, D. W., Babaian, R., Bast, R. C. Jr., Dowell, B., Esteva, F. J., Haglund, C., Harbeck, N., Hayes, D. F., Holten-Andersen, M., Klee, G. G., Lamerz, R., Looijenga, L. H., Molina, R., Nielsen, H. J., Rittenhouse, H., Semjonow, A., Shih, I.-M., Sibley, P., Soletormos, G., Stephan, C., Sokoll, L., Hoffman, B. R., Diamandis, E. P. (2008). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers. Clin. Chem. 54: e11-e79 [Abstract] [Full Text]  
• Brandt, A., Bermejo, J. L., Sundquist, J., Hemminki, K. (2008). Age of onset in familial cancer. Ann Oncol 19: 2084-2088 [Abstract] [Full Text]  
• Chan, J. A., Fuchs, C. S. (2008). Family History and Survival in Patients With Stage III Colorectal Cancer--Reply. JAMA 300: 1996-1997 [Full Text]  
• Pande, M., Amos, C. I., Osterwisch, D. R., Chen, J., Lynch, P. M., Broaddus, R., Frazier, M. L. (2008). Genetic Variation in Genes for the Xenobiotic-Metabolizing Enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and Susceptibility to Colorectal Cancer in Lynch Syndrome. Cancer Epidemiol. Biomarkers Prev. 17: 2393-2401 [Abstract] [Full Text]  
• Ziogas, D., Tsekeris, P., Fatourou, E. (2008). Benefits, Limitations, and Harm of Local Excision for Rectal Cancer. Ann. Surg. Oncol. 15: 2628-2629 [Full Text]  
• Kastrinos, F., Stoffel, E. M., Balmana, J., Steyerberg, E. W., Mercado, R., Syngal, S. (2008). Phenotype Comparison of MLH1 and MSH2 Mutation Carriers in a Cohort of 1,914 Individuals Undergoing Clinical Genetic Testing in the United States. Cancer Epidemiol. Biomarkers Prev. 17: 2044-2051 [Abstract] [Full Text]  
• Koessler, T, Oestergaard, M Z, Song, H, Tyrer, J, Perkins, B, Dunning, A M, Easton, D F, Pharoah, P D P (2008). Common variants in mismatch repair genes and risk of colorectal cancer. Gut 57: 1097-1101 [Abstract] [Full Text]  
• Zhang, L. (2008). Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome: Part II. The Utility of Microsatellite Instability Testing. J. Mol. Diagn. 10: 301-307 [Abstract] [Full Text]  
• Chan, J. A., Meyerhardt, J. A., Niedzwiecki, D., Hollis, D., Saltz, L. B., Mayer, R. J., Thomas, J., Schaefer, P., Whittom, R., Hantel, A., Goldberg, R. M., Warren, R. S., Bertagnolli, M., Fuchs, C. S. (2008). Association of Family History With Cancer Recurrence and Survival Among Patients With Stage III Colon Cancer. JAMA 299: 2515-2523 [Abstract] [Full Text]  
• Clendenning, M, Senter, L, Hampel, H, Robinson, K L., Sun, S, Buchanan, D, Walsh, M D, Nilbert, M, Green, J, Potter, J, Lindblom, A, de la Chapelle, A (2008). A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J. Med. Genet. 45: 340-345 [Abstract] [Full Text]  
• Ricci-Vitiani, L, Pagliuca, A, Palio, E, Zeuner, A, De Maria, R (2008). Colon cancer stem cells. Gut 57: 538-548 [Full Text]  
• Clendenning, M., Baze, M. E., Sun, S., Walsh, K., Liyanarachchi, S., Fix, D., Schunemann, V., Comeras, I., Deacon, M., Lynch, J. F., Gong, G., Thomas, B. C., Thibodeau, S. N., Lynch, H. T., Hampel, H., de la Chapelle, A. (2008). Origins and Prevalence of the American Founder Mutation of MSH2. Cancer Res. 68: 2145-2153 [Abstract] [Full Text]  
• Barber, T. D., McManus, K., Yuen, K. W. Y., Reis, M., Parmigiani, G., Shen, D., Barrett, I., Nouhi, Y., Spencer, F., Markowitz, S., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Lengauer, C., Hieter, P. (2008). Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl. Acad. Sci. USA 105: 3443-3448 [Abstract] [Full Text]  
• Hadley, D. W., Jenkins, J. F., Steinberg, S. M., Liewehr, D., Moller, S., Martin, J. C., Calzone, K. A., Soballe, P. W., Kirsch, I. R. (2008). Perceptions of Cancer Risks and Predictors of Colon and Endometrial Cancer Screening in Women Undergoing Genetic Testing for Lynch Syndrome. JCO 26: 948-954 [Abstract] [Full Text]  
• South, C. D., Hampel, H., Comeras, I., Westman, J. A., Frankel, W. L., de la Chapelle, A. (2008). The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families. JNCI J Natl Cancer Inst 100: 277-281 [Abstract] [Full Text]  
• Mao, G., Pan, X., Gu, L. (2008). Evidence That a Mutation in the MLH1 3'-Untranslated Region Confers a Mutator Phenotype and Mismatch Repair Deficiency in Patients with Relapsed Leukemia. J. Biol. Chem. 283: 3211-3216 [Abstract] [Full Text]  
• El-Shemerly, M., Hess, D., Pyakurel, A. K., Moselhy, S., Ferrari, S. (2008). ATR-dependent pathways control hEXO1 stability in response to stalled forks. Nucleic Acids Res 36: 511-519 [Abstract] [Full Text]  
• Gururangan, S., Frankel, W., Broaddus, R., Clendenning, M., Senter, L., McDonald, M., Eastwood, J., Reardon, D., Vredenburgh, J., Quinn, J., Friedman, H. S. (2008). Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation. Neuro Oncol 10: 93-97 [Abstract] [Full Text]  
• Masih, P. J., Kunnev, D., Melendy, T. (2008). Mismatch Repair proteins are recruited to replicating DNA through interaction with Proliferating Cell Nuclear Antigen (PCNA). Nucleic Acids Res 36: 67-75 [Abstract] [Full Text]  
• Kurnat-Thoma, E. L. (2008). Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses. Biol Res Nurs 9: 185-199 [Abstract]  
• Lynch, H. T., Lynch, J. F. (2008). Lynch Syndrome and the Role of the Registered Nurse: Commentary on "Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses". Biol Res Nurs 9: 200-202  
• East, J E, Suzuki, N, Stavrinidis, M, Guenther, T, Thomas, H J W, Saunders, B P (2008). Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut 57: 65-70 [Abstract] [Full Text]  
• Hemminki, K., Sundquist, J., Bermejo, J. L. (2008). How common is familial cancer?. Ann Oncol 19: 163-167 [Abstract] [Full Text]  
• Chu, D. Z. J., Gibson, G., David, D., Yen, Y. (2007). The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma. Ann. Surg. Oncol. 14: 3054-3069 [Abstract] [Full Text]  
• Aktan-Collan, K, Haukkala, A, Pylvanainen, K, Jarvinen, H J, Aaltonen, L A, Peltomaki, P, Rantanen, E, Kaariainen, H, Mecklin, J-P (2007). Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J. Med. Genet. 44: 732-738 [Abstract] [Full Text]  
• Rustgi, A. K. (2007). The genetics of hereditary colon cancer. Genes Dev. 21: 2525-2538 [Abstract] [Full Text]  
• Sanchez-de-Abajo, A., de la Hoya, M., van Puijenbroek, M., Tosar, A., Lopez-Asenjo, J.A., Diaz-Rubio, E., Morreau, H., Caldes, T. (2007). Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways. Clin. Cancer Res. 13: 5729-5735 [Abstract] [Full Text]  
• Harrington, J. M., Kolodner, R. D. (2007). Saccharomyces cerevisiae Msh2-Msh3 Acts in Repair of Base-Base Mispairs. Mol. Cell. Biol. 27: 6546-6554 [Abstract] [Full Text]  
• Pande, M., Chen, J., Amos, C. I., Lynch, P. M., Broaddus, R., Frazier, M. L. (2007). Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms C677T and A1298C on Age-Associated Risk for Colorectal Cancer in a Caucasian Lynch Syndrome Population. Cancer Epidemiol. Biomarkers Prev. 16: 1753-1759 [Abstract] [Full Text]  
• Lynch, H. T., Boland, C. R., Rodriguez-Bigas, M. A., Amos, C., Lynch, J. F., Lynch, P. M. (2007). Who Should Be Sent for Genetic Testing in Hereditary Colorectal Cancer Syndromes?. JCO 25: 3534-3542 [Abstract] [Full Text]  
• Chung, D. C., Yoon, S. S., Lauwers, G. Y., Patel, D. (2007). Case 22-2007 -- A Woman with a Family History of Gastric and Breast Cancer. NEJM 357: 283-291 [Full Text]  
• Scott, R. H, Homfray, T., Huxter, N. L, Mitton, S. G, Nash, R., Potter, M. N, Lancaster, D., Rahman, N. (2007). Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. J. Med. Genet. 44: e83-e83 [Abstract] [Full Text]  
• Skoglund, J., Song, B., Dalen, J., Dedorson, S., Edler, D., Hjern, F., Holm, J., Lenander, C., Lindforss, U., Lundqvist, N., Olivecrona, H., Olsson, L., Pahlman, L., Rutegard, J., Smedh, K., Tornqvist, A., Houlston, R. S., Lindblom, A. (2007). Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk. Clin. Cancer Res. 13: 3748-3752 [Abstract] [Full Text]  
• Mendillo, M. L., Putnam, C. D., Kolodner, R. D. (2007). Escherichia coli MutS Tetramerization Domain Structure Reveals That Stable Dimers but Not Tetramers Are Essential for DNA Mismatch Repair in Vivo. J. Biol. Chem. 282: 16345-16354 [Abstract] [Full Text]  
• Vasen, H F A, Moslein, G, Alonso, A, Bernstein, I, Bertario, L, Blanco, I, Burn, J, Capella, G, Engel, C, Frayling, I, Friedl, W, Hes, F J, Hodgson, S, Mecklin, J-P, Moller, P, Nagengast, F, Parc, Y, Renkonen-Sinisalo, L, Sampson, J R, Stormorken, A, Wijnen, J (2007). Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet. 44: 353-362 [Abstract] [Full Text]  
• Seiden, M. V., Patel, D., O'Neill, M. J., Oliva, E. (2007). Case 13-2007 -- A 46-Year-Old Woman with Gynecologic and Intestinal Cancers. NEJM 356: 1760-1769 [Full Text]  
• Raptis, S., Mrkonjic, M., Green, R. C., Pethe, V. V., Monga, N., Chan, Y. M., Daftary, D., Dicks, E., Younghusband, B. H., Parfrey, P. S., Gallinger, S. S., McLaughlin, J. R., Knight, J. A., Bapat, B. (2007). MLH1 -93G>A Promoter Polymorphism and the Risk of Microsatellite-Unstable Colorectal Cancer. JNCI J Natl Cancer Inst 99: 463-474 [Abstract] [Full Text]  
• U.S. Preventive Services Task Force*, (2007). Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. ANN INTERN MED 146: 361-364 [Abstract] [Full Text]  
• Lynch, H. T., Lynch, J. F., Lynch, P. M. (2007). Toward a Consensus in Molecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome). JNCI J Natl Cancer Inst 99: 261-263 [Full Text]  
• Wanat, J. J., Singh, N., Alani, E. (2007). The effect of genetic background on the function of Saccharomyces cerevisiae mlh1 alleles that correspond to HNPCC missense mutations. Hum Mol Genet 16: 445-452 [Abstract] [Full Text]  
• Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full Text]  
• Kitadai, Y., Sasaki, T., Kuwai, T., Nakamura, T., Bucana, C. D., Fidler, I. J. (2006). Targeting the Expression of Platelet-Derived Growth Factor Receptor by Reactive Stroma Inhibits Growth and Metastasis of Human Colon Carcinoma. Am. J. Pathol. 169: 2054-2065 [Abstract] [Full Text]  
• Niessen, R C, Berends, M J W, Wu, Y, Sijmons, R H, Hollema, H, Ligtenberg, M J L, de Walle, H E K, de Vries, E G E, Karrenbeld, A, Buys, C H C M, van der Zee, A G J, Hofstra, R M W, Kleibeuker, J H (2006). Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. Gut 55: 1781-1788 [Abstract] [Full Text]  
• Guillem, J. G., Wood, W. C., Moley, J. F., Berchuck, A., Karlan, B. Y., Mutch, D. G., Gagel, R. F., Weitzel, J., Morrow, M., Weber, B. L., Giardiello, F., Rodriguez-Bigas, M. A., Church, J., Gruber, S., Offit, K. (2006). ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes. JCO 24: 4642-4660 [Abstract] [Full Text]  
• Guillem, J. G., Wood, W. C., Moley, J. F., Berchuck, A., Karlan, B. Y., Mutch, D. G., Gagel, R. F., Weitzel, J., Morrow, M., Weber, B. L., Giardiello, F., Rodriguez-Bigas, M. A., Church, J., Gruber, S., Offit, K. (2006). ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes. Ann. Surg. Oncol. 13: 1296-1321 [Abstract] [Full Text]  
• De Felice, C, Gentile, M, Barducci, A, Bellosi, A, Parrini, S, Chitano, G, Latini, G (2006). Abnormal oral mucosal light reflectance: a new clinical marker of high risk for colorectal cancer. Gut 55: 1436-1439 [Abstract] [Full Text]  
• Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., Press, N. (2006). Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.. JAMA 296: 1507-1517 [Abstract] [Full Text]  
• Ford, J. M., Whittemore, A. S. (2006). Predicting and preventing hereditary colorectal cancer.. JAMA 296: 1521-1523 [Full Text]  
• Boland, C. R. (2006). Decoding hereditary colorectal cancer.. NEJM 354: 2815-2817 [Full Text]  
• Martinez, S. R., Young, S. E., Hoedema, R. E., Foshag, L. J., Bilchik, A. J. (2006). Colorectal Cancer Screening and Surveillance: Current Standards and Future Trends. Ann. Surg. Oncol. 13: 768-775 [Abstract] [Full Text]  
• Gorgens, H., Kruger, S., Kuhlisch, E., Pagenstecher, C., Hohl, R., Schackert, H. K., Muller, A. (2006). Microsatellite Stable Colorectal Cancers in Clinically Suspected Hereditary Nonpolyposis Colorectal Cancer Patients without Vertical Transmission of Disease Are Unlikely to Be Caused by Biallelic Germline Mutations in MYH. J. Mol. Diagn. 8: 178-182 [Abstract] [Full Text]  
• Black, D., Soslow, R. A., Levine, D. A., Tornos, C., Chen, S. C., Hummer, A. J., Bogomolniy, F., Olvera, N., Barakat, R. R., Boyd, J. (2006). Clinicopathologic Significance of Defective DNA Mismatch Repair in Endometrial Carcinoma. JCO 24: 1745-1753 [Abstract] [Full Text]  
• Zisman, A. L., Nickolov, A., Brand, R. E., Gorchow, A., Roy, H. K. (2006). Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening.. Arch Intern Med 166: 629-634 [Abstract] [Full Text]  
• Djureinovic, T, Skoglund, J, Vandrovcova, J, Zhou, X-L, Kalushkova, A, Iselius, L, Lindblom, A (2006). A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut 55: 362-366 [Abstract] [Full Text]  
• Heck, J. A., Argueso, J. L., Gemici, Z., Reeves, R. G., Bernard, A., Aquadro, C. F., Alani, E. (2006). Negative epistasis between natural variants of the Saccharomyces cerevisiae MLH1 and PMS1 genes results in a defect in mismatch repair. Proc. Natl. Acad. Sci. USA 103: 3256-3261 [Abstract] [Full Text]  
• Chao, E. C., Lipkin, S. M. (2006). Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res 34: 840-852 [Abstract] [Full Text]  
• Skoglund, J, Djureinovic, T, Zhou, X-L, Vandrovcova, J, Renkonen, E, Iselius, L, Bisgaard, M L, Peltomaki, P, Lindblom, A (2006). Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J. Med. Genet. 43: e07-e07 [Abstract] [Full Text]  
• Offit, K., Kauff, N. D. (2006). Reducing the Risk of Gynecologic Cancer in the Lynch Syndrome. NEJM 354: 293-295 [Full Text]  
• Hess, M. T., Mendillo, M. L., Mazur, D. J., Kolodner, R. D. (2006). Biochemical basis for dominant mutations in the Saccharomyces cerevisiae MSH6 gene. Proc. Natl. Acad. Sci. USA 103: 558-563 [Abstract] [Full Text]  
• Zhang, J., Lindroos, A., Ollila, S., Russell, A., Marra, G., Mueller, H., Peltomaki, P., Plasilova, M., Heinimann, K. (2006). Gene Conversion Is a Frequent Mechanism of Inactivation of the Wild-Type Allele in Cancers from MLH1/MSH2 Deletion Carriers. Cancer Res. 66: 659-664 [Abstract] [Full Text]  
• Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., Figg, W. D., Gospodarowicz, M. K., Hall, E. J., Hisada, M., Inskip, P., Kleinerman, R., Little, J. B., Malkin, D., Ng, A. K., Offit, K., Pui, C.-H., Robison, L. L., Rothman, N., Shields, P. G., Strong, L., Taniguchi, T., Tucker, M. A., Greene, M. H. (2006). Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. JNCI J Natl Cancer Inst 98: 15-25 [Abstract] [Full Text]  
• Knaebel, H.-P., Kienle, P. (2005). Patients at risk of familial colorectal cancer. BMJ 331: 1033-1034 [Full Text]  
• Douglas, J. A., Gruber, S. B., Meister, K. A., Bonner, J., Watson, P., Krush, A. J., Lynch, H. T. (2005). History and Molecular Genetics of Lynch Syndrome in Family G: A Century Later. JAMA 294: 2195-2202 [Abstract] [Full Text]  
• Chen, P.-C., Dudley, S., Hagen, W., Dizon, D., Paxton, L., Reichow, D., Yoon, S.-R., Yang, K., Arnheim, N., Liskay, R. M., Lipkin, S. M. (2005). Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse. Cancer Res. 65: 8662-8670 [Abstract] [Full Text]  
• Sotamaa, K., Liyanarachchi, S., Mecklin, J.-P., Jarvinen, H., Aaltonen, L. A., Peltomaki, P., de la Chapelle, A. (2005). p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome. Clin. Cancer Res. 11: 6840-6844 [Abstract] [Full Text]  
• Boland, C R, Luciani, M G, Gasche, C, Goel, A (2005). INFECTION, INFLAMMATION, AND GASTROINTESTINAL CANCER. Gut 54: 1321-1331 [Full Text]  
• De Felice, C, Parrini, S, Chitano, G, Gentile, M, Dipaola, L, Latini, G (2005). Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut 54: 1279-1282 [Abstract] [Full Text]  
• Boyd, J. (2005). Genetic Basis of Familial Endometrial Cancer: Is There More to Learn?. JCO 23: 4570-4573 [Full Text]  
• Mendillo, M. L., Mazur, D. J., Kolodner, R. D. (2005). Analysis of the Interaction between the Saccharomyces cerevisiae MSH2-MSH6 and MLH1-PMS1 Complexes with DNA Using a Reversible DNA End-blocking System. J. Biol. Chem. 280: 22245-22257 [Abstract] [Full Text]  
• Pool-Zobel, B. L., Selvaraju, V., Sauer, J., Kautenburger, T., Kiefer, J., Richter, K. K., Soom, M., Wolfl, S. (2005). Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 26: 1064-1076 [Abstract] [Full Text]  
• Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., Panescu, J., Fix, D., Lockman, J., Comeras, I., de la Chapelle, A. (2005). Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer). NEJM 352: 1851-1860 [Abstract] [Full Text]  
• Lynch, H. T., Lynch, P. M. (2005). Molecular Screening for the Lynch Syndrome -- Better Than Family History?. NEJM 352: 1920-1922 [Full Text]  
• Bian, Y., Caldes, T., Wijnen, J., Franken, P., Vasen, H., Kaklamani, V., Nafa, K., Peterlongo, P., Ellis, N., Baron, J. A., Burn, J., Moeslein, G., Morrison, P. J., Chen, Y., Ahsan, H., Watson, P., Lynch, H. T., de la Chapelle, A., Fodde, R., Pasche, B. (2005). TGFBR1{star}6A May Contribute to Hereditary Colorectal Cancer. JCO 23: 3074-3078 [Abstract] [Full Text]  
• El-Shemerly, M., Janscak, P., Hess, D., Jiricny, J., Ferrari, S. (2005). Degradation of Human Exonuclease 1b upon DNA Synthesis Inhibition. Cancer Res. 65: 3604-3609 [Abstract] [Full Text]  
• Lindor, N. M., Rabe, K., Petersen, G. M., Haile, R., Casey, G., Baron, J., Gallinger, S., Bapat, B., Aronson, M., Hopper, J., Jass, J., LeMarchand, L., Grove, J., Potter, J., Newcomb, P., Terdiman, J. P., Conrad, P., Moslein, G., Goldberg, R., Ziogas, A., Anton-Culver, H., de Andrade, M., Siegmund, K., Thibodeau, S. N., Boardman, L. A., Seminara, D. (2005). Lower Cancer Incidence in Amsterdam-I Criteria Families Without Mismatch Repair Deficiency: Familial Colorectal Cancer Type X. JAMA 293: 1979-1985 [Abstract] [Full Text]  
• Sangha, S, Yao, M, Wolfe, M M (2005). Non-steroidal anti-inflammatory drugs and colorectal cancer prevention. Postgrad. Med. J. 81: 223-227 [Abstract] [Full Text]  
• Radtke, F., Clevers, H. (2005). Self-Renewal and Cancer of the Gut: Two Sides of a Coin. Science 307: 1904-1909 [Abstract] [Full Text]  
• Gritz, E. R., Peterson, S. K., Vernon, S. W., Marani, S. K., Baile, W. F., Watts, B. G., Amos, C. I., Frazier, M. L., Lynch, P. M. (2005). Psychological Impact of Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer. JCO 23: 1902-1910 [Abstract] [Full Text]  
• Meyers, M., Wagner, M. W., Mazurek, A., Schmutte, C., Fishel, R., Boothman, D. A. (2005). DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage. J. Biol. Chem. 280: 5516-5526 [Abstract] [Full Text]  
• Casey, G., Lindor, N. M., Papadopoulos, N., Thibodeau, S. N., Moskow, J., Steelman, S., Buzin, C. H., Sommer, S. S., Collins, C. E., Butz, M., Aronson, M., Gallinger, S., Barker, M. A., Young, J. P., Jass, J. R., Hopper, J. L., Diep, A., Bapat, B., Salem, M., Seminara, D., Haile, R., for the Colon Cancer Family Registry, (2005). Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer. JAMA 293: 799-809 [Abstract] [Full Text]  
• Abel, E., Horner, S. D., Tyler, D., Innerarity, S. A. (2005). The Impact of Genetic Information on Policy and Clinical Practice. Policy Politics Nursing Practice 6: 5-14 [Abstract]  
• Tulchinsky, H., Keidar, A., Strul, H., Goldman, G., Klausner, J. M., Rabau, M. (2005). Extracolonic Manifestations of Familial Adenomatous Polyposis After Proctocolectomy. Arch Surg 140: 159-163 [Abstract] [Full Text]  
• Garber, J. E., Offit, K. (2005). Hereditary Cancer Predisposition Syndromes. JCO 23: 276-292 [Abstract] [Full Text]  
• Kievit, W, de Bruin, J H F M, Adang, E M M, Severens, J L, Kleibeuker, J H, Sijmons, R H, Ruers, T J, Nagengast, F M, Vasen, H F A, van Krieken, J H J M, Ligtenberg, M J L, Hoogerbrugge, N (2005). Cost effectiveness of a new strategy to identify HNPCC patients. Gut 54: 97-102 [Abstract] [Full Text]